glp 1 renal benefits Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations | Diabetes Therapy semaglutide and renal failure Kidney

It is not an approved drug, food, or dietary supplement and is not intended for human or animal consumption

Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) should avoid these medications due to the potential risk of thyroid C-cell tumors

Some patients might notice changes in mood or appetite regulation that require monitoring

As patents expire and potential generic or biosimilar versions emerge (e.g., generic liraglutide by Teva in 2024 ( [68] )), costs might come down, but for newer agents like semaglutide or tirzepatide, it could be years

Eine pauschale Dosierungsempfehlung lsst sich daher nicht festlegen